中国泪腺上皮性肿瘤诊疗专家共识(2021年)  

Chinese expert consensus on the diagnosis and treatment of epithelial tumors of the lacrimal gland(2021)

作　　者：中华医学会眼科学分会眼整形眼眶病学组 范先群[2] 李冬梅 孙丰源 肖利华 叶娟[7] Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association;Fan Xianqun(不详;Department of Ophthalmology,Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200011,China)

机构地区：[1]不详 [2]上海交通大学医学院附属第九人民医院眼科,200011 [3]首都医科大学附属北京同仁医院北京同仁眼科中心 [4]天津医科大学眼科医院 [5]解放军总医院眼科医学部 [6]北京美尔目定慧医院眼科 [7]浙江大学医学院附属第二医院眼科中心

出　　处：《中华眼科杂志》2021年第9期658-662,共5页Chinese Journal of Ophthalmology

摘　　要：泪腺区是眼眶肿瘤的好发部位。泪腺肿瘤约占眼眶占位性病变的10%,其中20%~50%为上皮性肿瘤,良性肿瘤占55%,恶性肿瘤占45%。泪腺上皮性肿瘤发病位置特殊,有一定的临床特异性,治疗原则与其他眼眶占位性病变存在一定区别,治疗不当极易造成肿瘤复发甚至恶变,严重影响患者预后及生活质量。鉴于此,中华医学会眼科学分会眼整形眼眶病学组专家经过认真讨论,共同提出泪腺上皮性肿瘤诊疗的专家共识意见,以期提高我国泪腺上皮性肿瘤的临床诊疗水平。(中华眼科杂志,2021,57:658-662)Orbital tumors frequently occur in the regions where the lacrimal gland is located.Lacrimal gland tumors account for about 10%of orbital space-occupying lesions.Among them,20%to 50%were epithelial tumors,with benign tumors accounting for 55%and malignant tumors accounting for 45%.Epithelial lacrimal gland tumors usually have a special location with relatively distinctive manifestations,and the treatment principle is different from other orbital space-occupying lesions.Improper treatment often leads to recurrence and even malignant transformation,which compromise the prognosis and life quality of patients.In view of this,the Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society has put forward the expert consensus on the diagnosis and treatment of epithelial lacrimal gland tumors after serious discussion,in order to improve the level of diagnosis and treatment of this disease in China.(Chin J Ophthalmol,2021,57:658-662)

关 键 词：泪器疾病 眼肿瘤 肿瘤 腺和上皮 诊疗准则(主题) 多数赞同 

分 类 号：R739.7[医药卫生—肿瘤]